09.01.2020 • NewsChemoursElaine Burridge

Chemours Sells Methylamines to Belle Chemical

Chemours Sells Methylamines to Belle Chemical
Chemours Sells Methylamines to Belle Chemical

Chemours has sold its methylamines business to Belle Chemical, an affiliate of Cornerstone Chemical, with effect from 1 January.

Interest in buying the business surfaced after Chemours announced last September that it would stop producing methylamines at its plant in Belle, West Virginia, USA, laying off 57 workers.

The decision was said to be driven by the rising costs of importing feedstocks such as methanol and ammonia along with the company’s wish to exit the business. Methylamines are used in a variety of applications in the agricultural, oil & gas, electronics and personal care industries, among others.

Chemours said it received “multiple inbound inquiries” from interested parties and hired investment bank Grace Matthews as an advisor.

Formerly the intermediate chemicals business of Cytec Industries, Cornerstone Chemical is owned by private equity firm Littlejohn & Co, which bought the Waggaman, Louisiana-based manufacturer from an affiliate of H.I.G. Capital in 2017.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read